the trigeminocervical complex (TCC). The development of the anti-migraine therapeutics, triptans-5-HT 1B/1D receptor agonists, had originally targeted the craniovasculature to exert therapeutic ...
collectively known as the trigeminocervical complex (TCC) is thought to explain the common distribution of pain in migraine. Drugs that target the TCC and inhibit neuronal activity in this region ...